Excedrin Migraine Full Migraine Indication Approved By FDA
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb's Excedrin Migraine indication for full migraine syndrome was approved by FDA Oct. 7. The new labeling simply bears the indication "Treats migraine."
You may also be interested in...
Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness
Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.
Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness
Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.
Advil Migraine Liqui-Gels Join Growing Category, Stress Distinctiveness
Upcoming marketing efforts accompanying the introduction of Whitehall-Robins' Advil Migraine Liqui-Gels likely will attempt to differentiate the product from its migraine-specific competitors by emphasizing the analgesic's speedy delivery form.